ÂÜÀòÂÒÂ×

Jack (Chung-Jr) Huang is currently a Senior Director of Process Development and Technology Transfer at AstraZeneca, specializing in mammalian cell culture process development, protein purification, and microbial fermentation. Previously, they served as Director of New Capabilities Process Development at Alexion Pharmaceuticals and held various positions at Merck, including Principal Scientist/Director, where they led biologics process research and development efforts. Jack completed a Ph.D. in Microbiology at Cornell University, following dual Bachelor's and Master's degrees from National Taiwan University. Their extensive experience includes significant roles in process commercialization, technology transfer, and regulatory interactions across multiple renowned organizations.